HOME >> MEDICINE >> NEWS
Actonel reduced nonveterbral fracture as early as 6 months

Further evidence of rapid fracture benefits with Actonel

San Francisco, Calif. (June 19, 2002) A new analysis shows Actonel (risedronate sodium tablets) reduced the risk of nonvertebral osteoporotic fractures by 74 percent within one year in postmenopausal women with osteoporosis. A significant reduction in the risk of nonvertebral fractures was observed as soon as six months. The effect of Actonel on nonvertebral fracture risk was based on a combined endpoint of the following sites: wrist, humerus, hip, pelvis, leg, and clavicle. The data were presented this week at the 84th Annual Meeting of The Endocrine Society in San Francisco.

"The ultimate goal of osteoporosis therapy is to prevent fractures," said J. T. Harrington, M.D., Associate Professor, Department of Medicine, University of Wisconsin Medical School, Madison, WI who was a lead investigator and presented the results today in a plenary session. "These study findings, combined with the consistent 1 year vertebral fracture reductions from previously published Actonel clinical trials, provide support for the rapid fracture benefits that Actonel provides across the skeleton."

The combined analysis included 1172 postmenopausal women with a lumbar spine T-score < -2.5 which is the World Health Organization (WHO) definition of osteoporosis. All patients received 1000 mg/d calcium in addition to either placebo or Actonel 5 mg daily. Nonvertebral fractures were collected as adverse events in three-month intervals and confirmed via x-ray. There was a statistically significant reduction in the risk of nonvertebral fractures as early as six months with a 74 percent reduction at one year (p=0.001, absolute risk reduction 3.3 percent).

According to the World Health Organization (WHO), osteoporosis is a significant and growing public health problem. The National Osteoporosis Foundation estimates that, in the United States, approximately 40 percent of women over 50 w
'"/>

Contact: Brian Devenny
bdevenny@hillandknowlton.com
212-885-0315
Hill and Knowlton
21-Jun-2002


Page: 1 2 3

Related medicine news :

1. Actonel helped preserve bone quality at five years, new data show
2. New analysis shows early intervention with Actonel reduces first vertebral fracture risk
3. FDA approves Actonel for once-a-week use
4. Study shows Actonel reduces vertebral fracture risk 70 percent in patients on chronic steroid therapy
5. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
6. Hypothyroidism associated with reduced breast cancer risk
7. Cocaine addicts show reduced brain structure that underlies judgment
8. Breast cancer risk, prognosis and weight gain reduced with physical activity
9. New analysis links breastfeeding to reduced risk of childhood leukemia
10. Teenage hormone therapy to reduce adult height of tall girls linked to reduced fertility
11. Biopharmaceutical manufacturing efficiencies signal reduced healthcare costs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/13/2017)... ATLANTA , Sept. 13, 2017   OrthoAtlanta ... to the Atlanta Football Host Committee (AFHC) for the 2018 ... Monday, Jan. 8, 2018, at Mercedes-Benz Stadium in ... part of the AFHC "I,m In" campaign, participating in many ... ...
Breaking Medicine Technology:
Cached News: